![Gordon Ringold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gordon Ringold
Directeur Général chez
Alavita Pharmaceuticals, Inc.
Profil
Gordon Ringold is the founder of Maxygen, Inc. (founded in 1997) and SurroMed, Inc. (founded in 1997).
He held the title of Independent Director at Maxygen, Inc. from 2011 to 2013 and Chairman & Chief Executive Officer at SurroMed, Inc. from 1997 to 2005.
Dr. Ringold currently holds multiple positions.
He is the Executive Chairman & Chief Executive Officer at Alavita Pharmaceuticals, Inc. since 2000.
He is also the Chief Executive Officer & Director at Quadriga BioSciences, Inc., Chairman at Maverix Biomics, Inc., Director at Protein Metrics, Inc., Director at Okava Pharmaceuticals, Inc., Director at Rapafusyn Pharmaceuticals, and Managing Partner at Technogen Associates LP.
In his former positions, Dr. Ringold served as the Chief Executive Officer at Affymax Research Institute from 1995 to 2000.
He was also the Chairman of Nanoplex Technologies, Inc. and Director-Cancer Biology at Syntex Corp.
from 1986 to 2010.
Additionally, he held the role of Independent Director at Alexza Pharmaceuticals, Inc. from 2001 to 2016, Non-Executive Director at Oxonica Ltd. in 2005, Senior Director at the University of California, Santa Cruz from 2010 to 2013, Independent Director at Sagimet Biosciences, Inc. from 2009 to 2023, Independent Director at Ardelyx, Inc. from 2014 to 2021, and Independent Director at Apexigen, Inc. from 2020 to 2023.
Dr. Ringold's education includes an undergraduate degree from the University of California, Santa Cruz and a doctorate degree from the University of California, San Francisco.
Postes actifs de Gordon Ringold
| Sociétés | Poste | Début |
|---|---|---|
Alavita Pharmaceuticals, Inc.
 Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapeutic products | Directeur Général | 01/01/2005 |
Maverix Biomics, Inc.
 Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cloud-based platform to manage, analyze and visualize genomic data | Président | - |
Technogen Associates LP | Corporate Officer/Principal | - |
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/01/2015 |
Protein Metrics, Inc.
 Protein Metrics, Inc. Information Technology ServicesTechnology Services Designs and publishes software for analytical scientists to clear scientific insights and develop new diagnostics and therapeutics | Directeur/Membre du Conseil | - |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Directeur/Membre du Conseil | 04/06/2020 |
Okava Pharmaceuticals, Inc.
 Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Directeur/Membre du Conseil | - |
Rapafusyn Pharmaceuticals
 Rapafusyn Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops non-degrading molecular glues and protein to tackle drug targets of kidney patients | Directeur/Membre du Conseil | - |
Anciens postes connus de Gordon Ringold
| Sociétés | Poste | Fin |
|---|---|---|
| APEXIGEN, INC. | Directeur/Membre du Conseil | 23/08/2023 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gordon Ringold
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Nanoplex Technologies, Inc.
 Nanoplex Technologies, Inc. BiotechnologyHealth Technology Produces encoded nanoparticles | Health Technology |
Alavita Pharmaceuticals, Inc.
Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapeutic products | Health Technology |
Protein Metrics, Inc.
Protein Metrics, Inc. Information Technology ServicesTechnology Services Designs and publishes software for analytical scientists to clear scientific insights and develop new diagnostics and therapeutics | Technology Services |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Oxonica Ltd.
 Oxonica Ltd. Miscellaneous Commercial ServicesCommercial Services Develops nanotechnology and commercial solutions | Commercial Services |
University of California, Santa Cruz
 University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SurroMed, Inc.
 SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical research | Commercial Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
Maverix Biomics, Inc.
Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides cloud-based platform to manage, analyze and visualize genomic data | Commercial Services |
Technogen Associates LP | |
Quadriga BioSciences, Inc.
Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Okava Pharmaceuticals, Inc.
Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops non-degrading molecular glues and protein to tackle drug targets of kidney patients | Health Technology |
